Targeting gene therapy directly into the lungs Professor Qiaobing Xu and team are able to greatly reduce tumors of a rare genetic lung disease using tiny lipid-based nanoparticles in a preclinical model. Research , Human health and bioengineering , Research news , Tufts Now , Engineers , Faculty , Graduate students
What is 3G and why is it being shut down? Associate Professor Mai Vu explains in an article for The Conversation. Research , Research news , Engineers , Faculty , Women engineers